NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ZZ Biotech

ZZ Biotech

Private
Houston, TexasHealthcare & Life Scienceshttps://zzbiotech.com/

Last Round

Grant

May 24, 2022

Total Funding Raised

$18.5M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

ZZ Biotech is a biotechnology company that develops biological treatments for ischemic stroke, amyotrophic lateral sclerosis (ALS), and other neurological diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts, Revenue Share

AI Layer

Non-AI

Keywords

ischemic stroke treatmentneuroprotective agent3K3A-APCbiologicsclinical stage biotechdrug developmentactivated protein CneurotherapeuticsALS treatmentclinical trialsgenetically engineered proteinamyotrophic lateral sclerosiswound healing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ZZ Biotech Comparables

Compare ZZ Biotech with similar companies based on industry and business-model similarity.

ZZ Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Merck
85%
NoNO Inc.
83%
Argenica Therapeutics
79%

ZZ Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 24, 2022
GrantJul 5, 2016
GrantDec 1, 2015
GrantApr 22, 2014
VC RoundApr 22, 2014
Private Equity
Oct 2, 2009

Key People

Founding team and executive leadership

Kent Pryor

Chief Executive Officer And Member, Board Of Managers

Executive Team

ZZ Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 18, 2026

    Monthly visitors grew 342% MoM, reaching 1.5K.

  • Mar 12, 2025

    Grew 133% QoQ, from 6 to 14 employees.

ZZ Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ZZ Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ZZ Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersHouston, Texas
Employee Range14
Year Founded2006
Last FundingMay 24, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.